Subchronic treatment with vanadate does not potentiate the toxicity of cardiac glycosides

Biological Trace Element Research
E MacDonaldH Komulainen

Abstract

Since it has been claimed that vanadate is an endogenous regulator of Na/K-ATPase activity and that it potentiates the toxicity of cardiac glycosides, we were alarmed to discover that certain Finnish physicians were prescribing vanadate in combination with other trace minerals to elderly patients for many different chronic diseases (e.g., cancer, rheumatism). To study the interaction of vanadate and cardiac glycosides, we fed vanadate in the drinking water (25 micrograms/mL) to guinea pigs for 20 d, and studied either their sensitivity to the acute toxicity of the cardiac glycoside ouabain or whether the vanadate would influence the subacute toxicity of ouabain. Vanadate had no influence on the toxicity of ouabain either acute or subchronically administered, nor was there any sign of inhibition of Na/K-ATPase activity as measured by 86Rb-uptake into intact erythrocytes (RBCs), RBC content of sodium or potassium or Na/K-ATPase activity in RBC membranes prepared from the vanadate-treated guinea pigs. Vanadate had been absorbed in substantial quantities from the gastrointestinal tract, since serum, heart, liver, and especially kidney contained measurable amounts of vanadium in contrast to controls, but it is concluded that this va...Continue Reading

References

Nov 16, 1979·Biochimica Et Biophysica Acta·T D MyersR L Post
Oct 26, 1978·Nature·W E BalfourI M Glynn
Aug 31, 1987·Biochemical and Biophysical Research Communications·S KadotaB I Posner
Sep 1, 1987·British Journal of Pharmacology·R A Nayler, H W Mitchell
Jan 1, 1985·Acta Medica Scandinavica·O Impivaara
May 7, 1981·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·K A Rubinson
Sep 3, 1983·Lancet·E MacDonald, K Hellevuo
Jan 1, 1984·Annual Review of Pharmacology and Toxicology·B R Nechay
Apr 17, 1980·Biochimica Et Biophysica Acta·I G MacaraL C Cantley
Oct 30, 1980·The New England Journal of Medicine·M De LuiseJ S Flier
Jan 1, 1983·European Journal of Clinical Pharmacology·A H FromK Ahmed
Apr 1, 1984·Biochemical Pharmacology·E ErdmannH Scholz
Jul 1, 1983·Acta Pharmacologica Et Toxicologica·H Komulainen
Jun 1, 1981·Pharmacological Research Communications·P Puig-ParelladaF G Valdecasas
Dec 1, 1982·The Journal of Nutrition·J D BogdenA Aviv

❮ Previous
Next ❯

Citations

Sep 1, 1994·Medical Hypotheses·J Matsumoto

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiac Glycosides

Cardiac glycosides are a diverse family of naturally derived compounds that bind to and inhibit na+/k+-atpase. Discover the latest research on cardiac glycosides heres.